Intervention effect of Chinese herb components HJJB Compound on PP1-DNA-PK-USF1 signaling pathway of non-alcoholic fatty liver rats

Hong-shan LI,Fei ZHOU,Ai-rong HU,De-zhou LI,Shao-dong CHEN
2017-01-01
Abstract:Objective:Toexplore the mechanism of Chinese herb component HJJB Compound on non-alcoholic fatty liver disease based on PP1-DNA-PK-USF1 signaling pathway.Methods:SD male rats were induced by high-fat diet for nonalcoholic fatty liver disease model.The rats were randomly divided into model group,HJJB group and rosiglitazone group,and were given intragastric administration for six weeks.The observing items including:liver pathology (HE staining);hepatic triglyceride (TG) and free fatty acid (FFA) content;mRNA and protein content changes of hepatic protein phosphatase 1 (PP1),DNA-dependent protein kinase (DNA-PK) and upstream stimulating factor 1 (USF1).Results:Significant hepatocyte fatty degeneration and vesicle changes were observed in liver tissue of model group.The hepatic TG and FFA contents of model group were significantly higher than those of normal group (P<0.01),and mRNA levels and protein contents of liver tissue PP1,DNA-PK,USF1 in model group were significantly higher than those in normal group (P<0.01).Hepatic pathological changes in HJJB Compound group were meliorated,liver tissue TG and FFA contents of HJJB Compound group were significantly lower than those of model group (P<0.01),and mRNA levels and protein contents of liver tissue PP1,DNA-PK,USF1 mRNA of HJJB Compound group were significantly lower than those of model group (P<0.01).Conclusion:HJJB Compound can significantly decrease mRNA level and protein content of PP1 in the liver tissue of fatty liver rats,and then inhibit the downstream signaling pathway of PP1,which may be an important mechanism of HJJB Compound for prevention and treatment of non-alcoholic fatty liver disease.
What problem does this paper attempt to address?